Journal
JOURNAL OF THE NATIONAL CANCER INSTITUTE
Volume 97, Issue 12, Pages 931-935Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/jnci/dji154
Keywords
-
Categories
Funding
- PHS HHS [N01-C0-12400] Funding Source: Medline
Ask authors/readers for more resources
The Birt-Rogg-Dube (BHD) syndrome is an inherited genodermatosis characterized by a predisposition to hamartomatous skin lesions, pulmonary cysts, and renal carcinoma. Seventy-seven renal tumors from 12 patients with germline BHD mutations were examined by DNA sequencing to identify somatic mutations in the second copy of BHD. Sequence alterations were detected in the majority of renal tumors (41 of 77, 53%), with loss of heterozygosity at the BHD focus in a minority of additional tumors (14 of 77, 17%). The somatic mutations were distributed across the entire gene, and the majority resulted in frameshifts that are predicted to truncate the BHD protein. These results support a role for BHD as a tumor suppressor gene that predisposes to the development of renal tumors when both copies are inactivated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available